Department of Genetics, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Blood. 2012 Dec 20;120(26):5118-27. doi: 10.1182/blood-2012-05-356014. Epub 2012 Sep 27.
Aberrations in the p53 tumor suppressor pathway are associated with hematologic malignancies. p53-dependent cell cycle control, senescence, and apoptosis functions are actively involved in maintaining hematopoietic homeostasis under normal and stress conditions. Whereas loss of p53 function promotes leukemia and lymphoma development in humans and mice, increased p53 activity inhibits hematopoietic stem cell function and results in myelodysplasia. Thus, exquisite regulation of p53 activity is critical for homeostasis. Most of our understanding of p53 function in hematopoiesis is derived from genetically engineered mice. Here we summarize some of these models, the various mechanisms that disrupt the regulation of p53 activity, and their relevance to human disease.
p53 肿瘤抑制途径的异常与血液恶性肿瘤有关。p53 依赖性细胞周期控制、衰老和细胞凋亡功能在正常和应激条件下积极参与维持造血平衡。虽然 p53 功能丧失会促进人类和小鼠的白血病和淋巴瘤的发展,但 p53 活性的增加会抑制造血干细胞的功能,并导致骨髓增生异常。因此,p53 活性的精细调节对于维持平衡至关重要。我们对 p53 在造血中的功能的大部分理解都来自于基因工程小鼠。在这里,我们总结了其中的一些模型,以及破坏 p53 活性调节的各种机制,及其与人类疾病的相关性。